| Literature DB >> 33390136 |
Raju Biswas1, Dipanjana Ghosh1, Bhramar Dutta1, Urmi Halder1, Prittam Goswami2, Rajib Bandopadhyay1.
Abstract
Cancer therapy describes the treatment of cancer, often with surgery, chemotherapy, and radiotherapy. Additionally, RNA interference (RNAi) is likely to be considered a new emerging, alternative therapeutic approach for silencing/targeting cancer-related genes. RNAi can exert antiproliferative and proapoptotic effects by targeting functional carcinogenic molecules or knocking down gene products of cancer-related genes. However, in contrast to conventional cancer therapies, RNAi based therapy seems to have fewer side effects. Transcription signal sequence and conserved sequence analysis-showed that microorganisms could be a potent source of non-coding RNAs. This review concluded that mapping of RNAi mechanism and RNAi based drug delivery approaches is expected to lead a better prospective of cancer therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Cancer therapy; RNA interference; RNAi based therapy; carcinogenic; drugs delivery; microorganisms
Year: 2021 PMID: 33390136 DOI: 10.2174/1566523220999201230204814
Source DB: PubMed Journal: Curr Gene Ther ISSN: 1566-5232 Impact factor: 4.391